Stockscreener 앱 받기
31.44
4.96%
-1.64
시간 외 거래:
31.66
0.22
+0.70%
전일 마감가:
$33.08
열려 있는:
$33.47
하루 거래량:
2.02M
Relative Volume:
3.60
시가총액:
$1.60B
수익:
$276.26M
순이익/손실:
$16.52M
주가수익비율:
102.14
EPS:
0.3078
순현금흐름:
$24.75M
1주 성능:
-2.66%
1개월 성능:
-15.23%
6개월 성능:
+5.36%
1년 성능:
-34.45%
1일 변동 폭
$30.67
$33.63
1주일 범위
$30.67
$34.34
52주 변동 폭
$29.24
$47.74
베리셀 Stock (VCEL) Company Profile
명칭
Vericel Corp
전화
(734) 930-5555
주소
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
31.44 | 1.68B | 276.26M | 16.52M | 24.75M | 0.3078 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
베리셀 Stock (VCEL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-08-09 | 개시 | Canaccord Genuity | Buy |
| 2024-06-20 | 개시 | TD Cowen | Buy |
| 2024-01-25 | 업그레이드 | Truist | Hold → Buy |
| 2023-08-08 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-11-09 | 다운그레이드 | Truist | Buy → Hold |
| 2022-10-14 | 재개 | Stephens | Overweight |
| 2021-01-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 개시 | Stephens | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2019-10-09 | 개시 | H.C. Wainwright | Buy |
| 2019-02-28 | 다운그레이드 | Needham | Buy → Hold |
| 2018-08-08 | 재확인 | Needham | Buy |
| 2018-07-16 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2018-04-04 | 개시 | Leerink Partners | Outperform |
| 2018-03-06 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2018-03-06 | 재확인 | Needham | Buy |
| 2018-03-05 | 재확인 | BTIG Research | Buy |
| 2017-06-21 | 개시 | BTIG Research | Buy |
| 2017-03-13 | 재확인 | Needham | Buy |
| 2016-12-22 | 개시 | Piper Jaffray | Overweight |
| 2016-11-09 | 재확인 | Needham | Buy |
| 2016-04-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2016-03-11 | 업그레이드 | Needham | Hold → Buy |
모두보기
베리셀 주식(VCEL)의 최신 뉴스
Vericel (NASDAQ:VCEL) Stock Price Down 4.9%Time to Sell? - MarketBeat
Vericel corp director Hagen sells $486k in shares - Investing.com
Vericel (VCEL) director sells 15,000 shares after option exercise - Stock Titan
Vericel Corporation $VCEL Position Increased by Congress Asset Management Co. - MarketBeat
[144] Vericel Corp SEC Filing - Stock Titan
Vericel Corp ($VCEL) CEO 2025 Pay Revealed - Quiver Quantitative
VCEL Stock Price, Quote & Chart | VERICEL CORP (NASDAQ:VCEL) - ChartMill
Vericel Corp. Experiences Revision in Its Stock Evaluation Amid Market Challenges - Markets Mojo
What Makes Vericel Corporation (VCEL) an Investment Bet? - Yahoo Finance
Dilated Cardiomyopathy Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Bristol Myers Squibb, Berlin Cures, Cumberland Pharma, Vericel Corp, Corimmun GmbH, Pfizer, Constant Therapeut - Barchart
Dilated Cardiomyopathy Market: Rapid Growth & Investment - openPR.com
Bank Watch: Can Vericel Corporation sustain earnings growth2026 Recap & Safe Entry Point Alerts - baoquankhu1.vn
Vericel at Leerink Global Healthcare: Strategic Growth and Expansion By Investing.com - Investing.com Australia
Vericel at Leerink Global Healthcare: Strategic Growth and Expansion - Investing.com South Africa
Leerink reiterates Outperform on Vericel stock, $46 target - Investing.com
FDA MACI Approval Tests Vericel’s Capacity Plans And Growth Story - Yahoo Finance
Vericel Corporation (VCEL) Secures FDA Approval for Commercial Manufacturing of MACI - Finviz
Vericel (VCEL) Valuation In Focus After FDA Clears MACI Commercial Manufacturing Capacity - simplywall.st
Vericel (NASDAQ:VCEL) Downgraded by Wall Street Zen to Hold - MarketBeat
Vericel (VCEL) Is Down 9.8% After FDA Clears New MACI Plant – Has The Bull Case Changed? - simplywall.st
Vericel wins FDA approval for MACI production at new facility - Investing.com
Insider Sell: Michael Halpin Sells 10,305 Shares of Vericel Corp (VCEL) - GuruFocus
Vericel wins FDA approval for MACI production at new facility By Investing.com - Investing.com Canada
Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion By Investing.com - Investing.com Australia
FDA Greenlights Vericel (VCEL) Facility for MACI Production - GuruFocus
Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility - The Manila Times
FDA approves new Vericel cell therapy plant to expand cartilage repair - Stock Titan
Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion - Investing.com
Sports injury and burn care firm Vericel heads to investor conferences - Stock Titan
Affiliate sale notice for Vericel (NASDAQ: VCEL) — 15,000 shares listed - Stock Titan
VCEL (NASDAQ: VCEL) Form 144 lists vested share sale entries - Stock Titan
H.C. Wainwright raises Vericel stock price target on revenue growth By Investing.com - Investing.com Canada
William Blair Investment Management LLC Buys 1,048,864 Shares of Vericel Corporation $VCEL - MarketBeat
H.C. Wainwright raises Vericel stock price target on revenue growth - Investing.com
Equities Analysts Offer Predictions for Vericel Q4 Earnings - Defense World
HC Wainwright Boosts Vericel (NASDAQ:VCEL) Price Target to $64.00 - Defense World
A Look At Vericel (VCEL) Valuation After Record 2025 Results And Upbeat 2026 Growth Guidance - Yahoo Finance
Should You Buy Vericel Corp (VCEL) Today? Analysis, Price Targets, and 2026 Outlook. - Intellectia AI
VCEL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Vericel (NASDAQ:VCEL) Given New $64.00 Price Target at HC Wainwright - MarketBeat
VCEL Analyst Rating: HC Wainwright & Co. Raises Price Target | V - GuruFocus
Vericel Corporation (NASDAQ:VCEL) Q4 2025 Earnings Call Transcript - Insider Monkey
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Breakout Case - ChartMill
Vericel (VCEL) EPS Jump In Q4 2025 Tests Premium 115x P/E Narrative - simplywall.st
Decoding Vericel Corp (VCEL): A Strategic SWOT Insight - GuruFocus
Vericel Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Vericel (NASDAQ:VCEL) Issues Quarterly Earnings Results - MarketBeat
Vericel (VCEL) CEO logs RSU vesting, phantom stock deferral and tax shares - Stock Titan
Vericel (VCEL) CMO logs RSU vesting, phantom stock and tax share withholdings - Stock Titan
RSU vesting boosts Vericel (VCEL) officer Siegal’s shareholding - Stock Titan
Vericel (VCEL) CFO logs RSU vesting and tax withholding share dispositions - Stock Titan
베리셀 (VCEL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):